假设性黏附素CAM87009.1分别以铝佐剂或生物源银纳米颗粒配制可保护小鼠免受多重耐药鲍曼不动杆菌致死性感染
研究将假设性黏附素蛋白CAM87009.1的重组形式(rCAM87009.1)分别与氢氧化铝(Alhydrogel®)或生物源银纳米颗粒(bio-AgNP)佐剂配制,在BALB/c小鼠模型中以三剂肌内注射免疫,再用多重耐药鲍曼不动杆菌MDR株(DL100)攻击。两种配方均保护100%动物免于致死性攻击,肺内未检出鲍曼不动杆菌菌落,IgG抗体滴度高(1:819,200)且两配方间统计学相似。
要点
- rCAM87009.1联合两种佐剂均保护100%小鼠免于多重耐药鲍曼不动杆菌致死性攻击。
- 两种配方免疫后肺内均未检出鲍曼不动杆菌菌落,IgG滴度达1:819,200且组间统计学相似。
- rCAM87009.1+bio-AgNP组组织损伤较Alhydrogel®组减轻。
核心结论
- rCAM87009.1蛋白与bio-AgNP及Alhydrogel®联合均能促进针对多重耐药鲍曼不动杆菌感染的免疫。
- 研究证明银纳米颗粒有潜力作为铝盐的替代佐剂分子。
研究设计与样本
- 研究将重组假设性黏附素蛋白rCAM87009.1分别与氢氧化铝(Alhydrogel®)或生物源银纳米颗粒(bio-AgNP)佐剂配制。
- 两种疫苗配方在BALB/c小鼠模型中以三剂肌内注射给药,免疫动物用多重耐药鲍曼不动杆菌MDR株(DL100)进行攻击试验。
主要发现
- rCAM87009.1蛋白联合两种佐剂在攻击期间保护100%受致死性菌株攻击的动物。
- 安乐死后,两种配方rCAM87009.1免疫动物肺内均未检出鲍曼不动杆菌菌落。
- 自首次免疫起即观察到高IgG抗体滴度(1:819,200),两种疫苗配方结果统计学相似。
- bio-AgNP配方诱导IgG2b和IgA,Alhydrogel®配方诱导IgA,两者均诱导IgG1(调理作用),bio-AgNP诱导IgM和IgG3、Alhydrogel®诱导IgM和IgG3(补体激活)。
- 与Alhydrogel®免疫动物相比,rCAM87009.1+bio-AgNP免疫动物组织损伤减轻。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Due to its antimicrobial resistance characteristics, the World Health Organization (WHO) classifies A. baumannii as one of the critical priority pathogens for the development of new therapeutic strategies. Vaccination has been approached as an interesting strategy to overcome the lack of effective antimicrobials and the long time required to develop and approve new drugs. In this study, we aimed to evaluate as a vaccine the hypothetical adhesin protein CAM87009.1 in its recombinant format (rCAM87009.1) associated with aluminum hydroxide (Alhydrogel®) or biogenic silver nanoparticles (bio-AgNP) as adjuvant components against lethal infection by A. baumannii MDR strain. Both vaccine formulations were administered in three doses intramuscularly in BALB/c murine models and the vaccinated animals were tested in a challenge assay with A. baumannii MDR strain (DL100). rCAM87009.1 protein associated with both adjuvants was able to protect 100 % of animals challenged with the lethal strain during the challenge period. After the euthanasia of the animals, no A. baumannii colonies were detected in the lungs of animals vaccinated with the rCAM87009.1 protein in both formulations. Since the first immunization, high IgG antibody titers were observed (1:819,200), with results being statistically similar in both vaccine formulations evaluated. rCAM87009.1 associated with both adjuvants was capable of inducing at least one class of isotypes associated with the processes of neutralization (IgG2b and IgA for bio-AgNP and Alhydrogel®, respectively), opsonization (IgG1 in both vaccines) and complement activation (IgM and IgG3 for bio-AgNP and Alhydrogel®, respectively). Furthermore, reduced tissue damage was observed in animals vaccinated with rCAM87009.1 + bio-AgNP when compared to animals vaccinated with Alhydrogel®. Our results indicate that the rCAM87009.1 protein associated with both bio-AgNP and Alhydrogel® are combinations capable of promoting immunity against infections caused by A. baumannii MDR. Additionally, we demonstrate the potential of silver nanoparticles as alternative adjuvant molecules to the use of aluminum salts.
引用
- Buchhorn de Freitas S, Clair Pinto Seixas Neto A, Aparecido Panagio L, et al. Hypothetical adhesin CAM87009.1 formulated in alum or biogenic silver nanoparticles protects mice from lethal infection by multidrug-resistant Acinetobacter baumannii. Vaccine. 2024. PMID: 38719690. doi:10.1016/j.vaccine.2024.04.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。